Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-257618

Chief Development Officer sold 20,000 shares at $70.60 ($1,412,000)

  • Chief Development Officer acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2026-06-02 Option exercise 10b5-1 +20,000 $21.65 $433,000 23,985 D: show line 1 in the form
Guyer William Chief Development Officer 2026-06-02 Sale 10b5-1 −20,000 $70.60 $1,412,000 3,985 D: show line 2 in the form
Open-market sales · 20,000 sh · avg $70.60 · $1,412,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Guyer William Chief Development Officer 2026-06-02 Option exercise · Stock Option (right to buy) 10b5-1 −20,000 150,000 D: show line 3 in the form
Loading xslF345X06/ownership.xml…